Filter
716
Filtered Results: 716
Text search:
FDA
Featured
Recommendations
95
New Publications
139
Language
Document type
No document type
333
Guidelines
198
Studies & Reports
93
Manuals
28
Fact sheets
25
Strategic & Response Plan
19
Training Material
9
Infographics
4
Resource Platforms
3
Brochures
2
Situation Updates
2
Countries / Regions
India
40
Ghana
22
Latin America and the Carribbean
22
Russia
17
Philippines
15
Global
14
Germany
12
Brazil
12
Myanmar / Burma
12
Congo, Democratic Republic of
11
South Africa
10
Middle East and North Africa
9
Kenya
8
West and Central Africa
8
Syria
7
Nigeria
7
USA
7
Argentina
7
Ecuador
7
Colombia
6
Ukraine
6
Senegal
6
Western and Central Europe
6
Uganda
6
Yemen
6
Angola
6
Sierra Leone
5
Mozambique
5
Paraguay
5
Eastern Europe
5
Ethiopia
5
South Sudan
5
Indonesia
5
Nepal
4
Thailand
4
Rwanda
4
Burkina Faso
4
Peru
4
Eastern Europe and Central Asia
4
France
4
East and Southern Africa
4
Sudan
4
Mali
4
Liberia
4
Benin
3
Chile
3
Guinea
3
Africa
3
Venezuela
3
Tanzania
3
South–East Asia Region
3
Spain
3
Bolivia
3
Bangladesh
3
Tajikistan
2
El Salvador
2
Albania
2
Niger
2
Haiti
2
Asia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Namibia
2
Iraq
2
Mexico
1
Turkey
1
Kazakhstan
1
Cameroon
1
Singapore
1
Congo-Brazzaville
1
Malawi
1
Zimbabwe
1
Morocco
1
Qatar
1
Mauritania
1
Armenia
1
Cambodia
1
Dominican Republic
1
Tunisia
1
United Kingdom
1
Belarus
1
Israel
1
Lebanon
1
Nicaragua
1
Moldova
1
Egypt
1
Honduras
1
Chad
1
Libya
1
Botswana
1
Somalia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
233
Clinical Guidelines
88
Pharmacy & Technologies
24
Women & Child Health
20
Public Health
15
Key Resources
11
Capacity Building
5
Toolboxes
COVID-19
159
Mental Health
71
TB
62
HIV
53
Pharmacy
38
AMR
36
Ebola & Marburg
31
Rapid Response
19
NTDs
15
Specific Hazards
13
NCDs
12
Planetary Health
10
Zika
9
Malaria
8
Refugee
7
Cholera
5
Caregiver
5
Natural Hazards
4
2.0 Rapid Response
3
Conflict
3
Global Health Education
3
Health Financing Toolbox
2
Disability
1
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
Ce rapport présente une analyse de l'OMS sur les pénuries et le manque de disponibilité des antibiotiques hors brevet en France prenant en compte l'approche Une seule santé. Le rapport est organisé en deux sections : santé animale et santé humaine.
Le rapport vise à donner un éclairage sur...
Troubles anxieux
Chapitre F.1
Edition en français Traduction : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
Introduction
Chapter A.7
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of...
